Exploration of Prostate Cancer Cells: The Significance of Active HERV
Location
Taylor 302, Madison Union, JMU
Start Date
4-6-2019 1:40 PM
Description
The second most common cancer in men is prostate cancer. Prostate cancer is traditionally diagnosed by a digital rectal exam. Blood tests can also be used to test for PSA (prostate-specific antigen). These two methods can be used together but can sometimes provide both false negative and false positive results. A new method of testing for prostate cancer could prove to be beneficial. Previous studies have shown that active HERV sequences have been identified in some cancers, including prostate cancer. We hypothesize that the presence of active HERV in prostate cancer lines is significant. In this study, rabbit polyclonal antibodies and Western blotting were used to assay for the presence of HERV protein products after 5-aza-2’-deoxycytidine was used to amplify transcripts of prostate cancer-specific genes. Positive results may suggest a new method to detect prostate cancer in patient samples.
Presentation Type
Presentation
Exploration of Prostate Cancer Cells: The Significance of Active HERV
Taylor 302, Madison Union, JMU
The second most common cancer in men is prostate cancer. Prostate cancer is traditionally diagnosed by a digital rectal exam. Blood tests can also be used to test for PSA (prostate-specific antigen). These two methods can be used together but can sometimes provide both false negative and false positive results. A new method of testing for prostate cancer could prove to be beneficial. Previous studies have shown that active HERV sequences have been identified in some cancers, including prostate cancer. We hypothesize that the presence of active HERV in prostate cancer lines is significant. In this study, rabbit polyclonal antibodies and Western blotting were used to assay for the presence of HERV protein products after 5-aza-2’-deoxycytidine was used to amplify transcripts of prostate cancer-specific genes. Positive results may suggest a new method to detect prostate cancer in patient samples.